Table:
LH	Androstenedione
Preoperative	Postoperative	P	Preoperative	Postoperative	P
Total study population	15.1 ± 6.0	6.4 ± 4.0	< 0.001	3.2 ± 0.9	2.2 ± 1.6	< 0.001
LH	≤12.1 IU/l	8.4 ± 2.2	6.1 ± 3.3	0.004	3.1 ± 1.0	3.0 ± 2.7	0.708
>12.1 IU/l	18.0 ± 4.6	6.6 ± 4.3	< 0.001	3.2 ± 0.9	1.9 ± 0.7	< 0.001
Androstenedione	≤3.26 mg/dl	14.5 ± 5.4	6.5 ± 4.3	< 0.001	2.6 ± 0.5	1.8 ± 0.6	< 0.001
>3.26 mg/dl	16.0 ± 6.7	6.4 ± 3.5	< 0.001	6.4 ± 0.9	2.7 ± 2.3	< 0.001
LH and androstenedione	LH ≤ 12.1 IU/l or androstenedione ≤ 3.26 mg/dl	13,7 ± 5,4	6,6 ± 4,0	< 0.001	2.8 ± 0.8	2.3 ± 2.0	0.029
LH >12.1 IU/l and androstenedione >3.26 mg/dl	18,3 ± 5,9	6,1 ± 4,0	< 0.001	3.9 ± 0.8	2.0 ± 0.6	< 0.001

Express the picture as Markdown code.

|  |  | <COLSPAN=3> LH | <COLSPAN=3> Androstenedione | 
 |  |  | Preoperative | Postoperative | P | Preoperative | Postoperative | P | 
 | --- | --- | --- | --- | --- | --- | --- | --- | 
 | Total study population |  | 15.1 ± 6.0 | 6.4 ± 4.0 | < 0.001 | 3.2 ± 0.9 | 2.2 ± 1.6 | < 0.001 | 
 | LH | ≤12.1 IU/l | 8.4 ± 2.2 | 6.1 ± 3.3 | 0.004 | 3.1 ± 1.0 | 3.0 ± 2.7 | 0.708 | 
 |  | >12.1 IU/l | 18.0 ± 4.6 | 6.6 ± 4.3 | < 0.001 | 3.2 ± 0.9 | 1.9 ± 0.7 | < 0.001 | 
 | Androstenedione | ≤3.26 mg/dl | 14.5 ± 5.4 | 6.5 ± 4.3 | < 0.001 | 2.6 ± 0.5 | 1.8 ± 0.6 | < 0.001 | 
 |  | >3.26 mg/dl | 16.0 ± 6.7 | 6.4 ± 3.5 | < 0.001 | 6.4 ± 0.9 | 2.7 ± 2.3 | < 0.001 | 
 | LH and androstenedione | LH ≤ 12.1 IU/l or androstenedione ≤ 3.26 mg/dl | 13,7 ± 5,4 | 6,6 ± 4,0 | < 0.001 | 2.8 ± 0.8 | 2.3 ± 2.0 | 0.029 | 
 |  | LH >12.1 IU/l and androstenedione >3.26 mg/dl | 18,3 ± 5,9 | 6,1 ± 4,0 | < 0.001 | 3.9 ± 0.8 | 2.0 ± 0.6 | < 0.001 |